Over the last decade, AKR1B10, has emerged as a potential biomarker for the diagnosis and prognosis of HCC, with experimental studies demonstrating roles for this enzyme in biological pathways underlying the development and progression of HCC [109]. Here, AKR1B10 is linked to hepatocellular carcinoma.